DA ZEN THERANOSTICS
Da Zen Theranostics develop a product that can target cancer cells, function as a contrast agent to improve the visibility of cancer cells. It functions as a contrast agent to improve the visibility of cancer cells during diagnostic imaging and deliver a therapeutic drug to destroy cancerous cells. The product will be based on a chemical compound that was created by Dr. Maged Henary, associate professor of chemistry at Georgia State. Henary’s chemical compound, a heptamethine cyanine also known to the scientific community as MHI-148, is already being used internationally in cancer imaging research. The company was founded in 2017 and is based in San Jose, California.
DA ZEN THERANOSTICS
Industry:
Biotechnology Therapeutics
Founded:
2017-01-01
Address:
San Jose, California, United States
Country:
United States
Website Url:
http://www.dazenthera.com
Total Employee:
1+
Status:
Active
Contact:
408-489-9383
Total Funding:
2.3 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API Google Analytics Apache Euro Google Apps For Business ReCAPTCHA AJAX Libraries API
Similar Organizations
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Jounce Therapeutics
Jounce Therapeutics is developing cancer immune-therapies to harness the immune system to attack cancerous cells and tumors.
Spero Therapeutics
Spero Therapeutics is developing first in class therapeutics for treatment of gram-negative infections.
Current Employees Featured
Founder
Official Site Inspections
http://www.dazenthera.com
- Host name: pages-custom-19.weebly.com
- IP address: 199.34.228.67
- Location: San Francisco United States
- Latitude: 37.7642
- Longitude: -122.3993
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94107
